BREAST NEOPLASM
Clinical trials for BREAST NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new BREAST NEOPLASM trials appear
Sign up with your email to follow new studies for BREAST NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for advanced breast cancer: new combo targets resistant tumors
Disease control OngoingThis study tests whether adding abemaciclib to fulvestrant can slow or stop the growth of a common type of advanced breast cancer (HR+, HER2-) that has worsened after initial treatment. About 368 participants will receive either the drug combo or a placebo plus fulvestrant. The g…
Matched conditions: BREAST NEOPLASM
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New radiation technique aims to spare heart in breast cancer patients
Disease control OngoingThis study is testing a precise type of radiation called proton therapy for women with stage II or III breast cancer who need radiation to the whole breast or chest wall and lymph nodes. The goal is to see if this approach causes fewer side effects, especially to the heart, compa…
Matched conditions: BREAST NEOPLASM
Phase: PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 13:57 UTC
-
Radioactive tracer could reveal breast Cancer's inner workings
Diagnosis OngoingThis early-stage study tests a new radioactive tracer called [18F]ISO-1 in PET scans for people with breast cancer. The tracer targets sigma-2 receptors, which are linked to how fast cancer cells multiply. Researchers want to see if the scan can measure tumor growth rates and hel…
Matched conditions: BREAST NEOPLASM
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Can a simple letter boost breast cancer screening? singapore study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests five different reminder strategies to encourage women in Singapore who are overdue for mammograms to get screened. About 12,750 women aged 50-69 who have not had a mammogram in over two years will receive reminders by mail, with some getting a pre-scheduled appoi…
Matched conditions: BREAST NEOPLASM
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New program aims to help breast cancer survivors get back to work
Knowledge-focused OngoingThis study tests a new program to help breast cancer patients return to work after treatment. It includes 16 working-age women who have work difficulties. The program offers meetings and support from a team of specialists. The goal is to see if this approach is practical and help…
Matched conditions: BREAST NEOPLASM
Phase: NA • Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New website aims to ease tough fertility choices for women with cancer
Knowledge-focused OngoingThis study tests a decision aid website called Pathways to Fertility for women newly diagnosed with cancer who may face infertility from treatment. About 130 women will use the website or receive standard care to see if it helps them make more informed and less conflicted decisio…
Matched conditions: BREAST NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks nerve pain from breast cancer drug
Knowledge-focused OngoingThis study follows 36 people with HER2-positive breast cancer who are receiving the drug T-DM1. Researchers want to learn how often and how severely the drug causes nerve damage (peripheral neuropathy), such as numbness, tingling, or pain. Participants will report their symptoms …
Matched conditions: BREAST NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New scan could reveal if breast cancer drugs are working in days
Knowledge-focused OngoingThis early-phase study tests whether a special PET scan using a tracer called FLT can show how breast cancer tumors respond to a combination of two drugs, ribociclib and paclitaxel. The study involves 20 people with metastatic breast cancer that has spread beyond the liver and bo…
Matched conditions: BREAST NEOPLASM
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:37 UTC